PTC Therapeutics Inc (PTCT) Stock deserves your attention

Morgan Stanley raised the price target for the PTC Therapeutics Inc (NASDAQ:PTCT) stock from “an Equal-weight” to “an Underweight”. The rating was released on December 19, 2023, according to finviz. The research report from Oppenheimer has upgraded the stock from Perform to Outperform, with a price target set at $165. The stock was downgraded by […]

The growth of PTC Therapeutics Inc (PTCT) Stock is expected to continue

Morgan Stanley raised the price target for the PTC Therapeutics Inc (NASDAQ:PTCT) stock from “an Equal-weight” to “an Underweight”. The rating was released on December 19, 2023, according to finviz. The research report from Oppenheimer has upgraded the stock from Perform to Outperform, with a price target set at $165. The stock was downgraded by […]

Why PTC Therapeutics Inc (NASDAQ:PTCT) Stock rose 23.94% in Last Six Months?

Morgan Stanley raised the price target for the PTC Therapeutics Inc (NASDAQ:PTCT) stock from “an Equal-weight” to “an Underweight”. The rating was released on December 19, 2023, according to finviz. The research report from Oppenheimer has upgraded the stock from Perform to Outperform, with a price target set at $165. The stock was downgraded by […]

What makes PTC Therapeutics Inc (PTCT) Stock unique?

Morgan Stanley raised the price target for the PTC Therapeutics Inc (NASDAQ:PTCT) stock from “an Equal-weight” to “an Underweight”. The rating was released on December 19, 2023, according to finviz. The research report from Oppenheimer has upgraded the stock from Perform to Outperform, with a price target set at $165. The stock was downgraded by […]